Genetic studies of accelerometer-based sleep measures yield new insights into human sleep behaviour

Nature Communications

Volumn 10, Issue 1, 2019, Pages

  Jones, Samuel E ^a   van Hees, Vincent T ^b   Mazzotti, Diego R ^c,d   Marques Vidal, Pedro ^e   Sabia, Séverine ^f,g   van der Spek, Ashley ^h   Dashti, Hassan S ^i,j   Engmann, Jorgen ^f   Kocevska, Desana ^h   Tyrrell, Jessica ^a   Beaumont, Robin N ^a   Hillsdon, Melvyn ^a   Ruth, Katherine S ^a   Tuke, Marcus A ^a   Yaghootkar, Hanieh ^a   Sharp, Seth A ^a   Ji, Yingjie ^a   Harrison, Jamie W ^a   Freathy, Rachel M ^a   Murray, Anna ^a   Luik, Annemarie I ^h   Amin, Najaf ^h   Lane, Jacqueline M ^i,j   Saxena, Richa ^i,k   Rutter, Martin K ^l,m   Tiemeier, Henning ^h,n   Kutalik, Zoltán ^o,p   Kumari, Meena ^q   Frayling, Timothy M ^a   Weedon, Michael N ^a   Gehrman, Philip R ^c,d   Wood, Andrew R ^a   more..

^a UNIVERSITY OF EXETER   (United Kingdom)

^b NETHERLANDS ESCIENCE CENTER   (Netherlands)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o UNIVERSITY OF LAUSANNE   (Switzerland)

^p SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^q UNIVERSITY OF ESSEX   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; TRANSCRIPTION FACTOR PAX8;

ACCELEROMETER; BEHAVIORAL RESPONSE; GENE EXPRESSION; GENETIC ANALYSIS; MODEL VALIDATION; NOCTURNAL ACTIVITY; PHYSIOLOGICAL RESPONSE; SLEEP;

ACCELEROMETRY; ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; DEPRESSION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIATION; GENETICS; GENOME; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; INSOMNIA; LIFESTYLE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PHYLOGENY; PHYSICAL INACTIVITY; PRINCIPAL COMPONENT ANALYSIS; RESTLESS LEGS SYNDROME; SELF REPORT; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; SLEEP TIME; SOMNOLENCE; WAIST HIP RATIO; WAKEFULNESS; CIRCADIAN RHYTHM; METABOLISM; POLYSOMNOGRAPHY; PROCEDURES; SLEEP;

UNITED KINGDOM;

ACCELEROMETRY; CIRCADIAN RHYTHM; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYSOMNOGRAPHY; SEROTONIN; SLEEP; SLEEP WAKE DISORDERS; WAIST-HIP RATIO;

EID: 85064000172     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-019-09576-1     Document Type: Article

References (77)

1. Fernandez-Mendoza, J. & Vgontzas, A. N. Insomnia and its impact on physical and mental health. Curr. Psychiatry Rep. 15, 418 (2013).
2. He, Q., Zhang, P., Li, G., Dai, H. & Shi, J. The association between insomnia symptoms and risk of cardio-cerebral vascular events: A meta-analysis of prospective cohort studies. Eur. J. Prev. Cardiol. 24, 1071–1082 (2017).
3. Luyster, F. S. et al. Sleep: a health imperative. Sleep 35, 727–734 (2012).
4. Spira, A. P., Chen-Edinboro, L. P., Wu, M. N. & Yaffe, K. Impact of sleep on the risk of cognitive decline and dementia. Curr. Opin. Psychiatry 27, 478–483 (2014).
5. Sterniczuk, R., Theou, O., Rusak, B. & Rockwood, K. Sleep disturbance is associated with incident dementia and mortality. Curr. Alzheimer. Res. 10, 767–775 (2013).
6. McNeil, J., Doucet, E. & Chaput, J. P. Inadequate sleep as a contributor to obesity and type 2 diabetes. Can. J. Diabetes 37, 103–108 (2013).
7. Nedeltcheva, A. V. & Scheer, F. A. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 21, 293–298 (2014).
8. Taheri, S. The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch. Dis. Child 91, 881–884 (2006).
9. Watanabe, M., Kikuchi, H., Tanaka, K. & Takahashi, M. Association of short sleep duration with weight gain and obesity at 1-year follow-up: a large-scale prospective study. Sleep 33, 161–167 (2010).
10. Xiao, Q., Arem, H., Moore, S. C., Hollenbeck, A. R. & Matthews, C. E. A large prospective investigation of sleep duration, weight change, and obesity in the NIH-AARP Diet and Health Study cohort. Am. J. Epidemiol. 178, 1600–1610 (2013).
11. Gottlieb, D. J. et al. Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study. Mol. Psychiatry 20, 1232–1239 (2015).
12. Jones, S. E. et al. Genome-wide association analyses in 128,266 individuals identifies new morningness and sleep duration loci. PLoS Genet. 12, e1006125 (2016).
13. Lane, J. M. et al. Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits. Nat. Genet. 49, 274–281 (2017).
14. Dashti, H. S. et al. Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates. Nat. Commun. 10, 1100 (2019).
15. Hu, Y. et al. GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person. Nat. Commun. 7, 10448 (2016).
16. Lane, J. M. et al. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat. Commun. 7, 10889 (2016).
17. Byrne, E. M. et al. A genome-wide association study of sleep habits and insomnia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 162B, 439–451 (2013).
18. Hammerschlag, A. R. et al. Genome-wide association analysis of insomnia complaints identifies risk genes and genetic overlap with psychiatric and metabolic traits. Nat. Genet. 49, 1584–1592 (2017).
19. Jansen, P. R. et al. Genome-wide analysis of insomnia (N=1,331,010) identifies novel loci and functional pathways. bioRxiv, 214973 (2018).
20. Lane, J. M. et al. Biological and clinical insights from genetics of insomnia symptoms. Nat. Genet. 51, 387–393 (2019).
21. Stein, M. B. et al. Genome-wide analysis of insomnia disorder. Mol. Psychiatry 23, 2238–2250 (2018).
22. Arora, T., Broglia, E., Pushpakumar, D., Lodhi, T. & Taheri, S. An investigation into the strength of the association and agreement levels between subjective and objective sleep duration in adolescents. PLoS ONE 8, e72406 (2013).
23. Bianchi, M. T., Williams, K. L., McKinney, S. & Ellenbogen, J. M. The subjective-objective mismatch in sleep perception among those with insomnia and sleep apnea. J. Sleep. Res. 22, 557–568 (2013).
24. Lauderdale, D. S., Knutson, K. L., Yan, L. L., Liu, K. & Rathouz, P. J. Self-reported and measured sleep duration: how similar are they? Epidemiology 19, 838–845 (2008).
25. Miller, C. B. et al. Agreement between simple questions about sleep duration and sleep diaries in a large online survey. Sleep Health 1, 133–137 (2015).
26. Ritter, P. S., Sauer, C., Pfeiffer, S. & Bauer, M.,. & Pfennig, A. Comparison of subjective and objective sleep estimations in patients with bipolar disorder and healthy control subjects. Sleep Disord. 2016, 4031535 (2016).
27. Lee, I. M. et al. Accelerometer-measured physical activity and sedentary behavior in relation to all-cause mortality: The Women’s Health Study. Circulation 137, 203–205 (2018).
28. Mitchell, J. A. et al. A prospective study of sedentary behavior in a large cohort of youth. Med. Sci. Sports. Exerc. 44, 1081–1087 (2012).
29. van Hees, V. T. et al. A novel, open access method to assess sleep duration using a wrist-worn accelerometer. PLoS ONE 10, e0142533 (2015).
30. van Hees, V. T. et al. Estimating sleep parameters using an accelerometer without sleep diary. Sci. Rep. 8, 12975 (2018).
31. Jones, S. E. et al. Genome-wide association analyses of chronotype in 697,828 individuals provides insights into circadian rhythms. Nat. Commun. 10, 343 (2019).
32. Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).
33. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
34. Loh, P. R., Kichaev, G., Gazal, S., Schoech, A. P. & Price, A. L. Mixed-model association for biobank-scale datasets. Nat. Genet. 50, 906–908 (2018).
35. Schormair, B. et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 16, 898–907 (2017).
36. Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).
37. Lim, A. S. et al. Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 70, 1544–1551 (2013).
38. McCurry, S. M. et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J. Geriatr. Psychiatry Neurol. 12, 53–59 (1999).
39. Pollak, C. P. & Perlick, D. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiatry Neurol. 4, 204–210 (1991).
40. Vanderheyden, W. M., Lim, M. M., Musiek, E. S. & Gerstner, J. R. Alzheimer’s disease and sleep-wake disturbances: Amyloid, astrocytes, and animal models. J. Neurosci. 38, 2901–2910 (2018).
41. Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
42. Carithers, L. J. et al. A novel approach to high-quality postmortem tissue procurement: The GTEx project. Biopreserv. Biobank. 13, 311–319 (2015).
43. Lee, C., Wallingford, J. B. & Gross, J. M. Cluap1 is essential for ciliogenesis and photoreceptor maintenance in the vertebrate eye. Invest. Ophthalmol. Vis. Sci. 55, 4585–4592 (2014).
44. de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
45. Sodini, S. M., Kemper, K. E., Wray, N. R. & Trzaskowski, M. Comparison of genotypic and phenotypic correlations: Cheverud’s conjecture in humans. Genetics 209, 941–948 (2018).
46. Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).
47. Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 48, 856–866 (2016).
48. Horvath, A. et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res. 66, 11571–11575 (2006).
49. Kelly, M. P. A role for phosphodiesterase 11A (PDE11A) in the formation of social memories and the stabilization of mood. Adv. Neurobiol. 17, 201–230 (2017).
50. Monti, J. M. & Jantos, H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog. Brain Res. 172, 625–646 (2008).
51. Ursin, R. Serotonin and sleep. Sleep. Med. Rev. 6, 55–69 (2002).
52. Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E. & McCarley, R. W. Control of sleep and wakefulness. Physiol. Rev. 92, 1087–1187 (2012).
53. El Gewely, M. et al. Reassessing GWAS findings for the shared genetic basis of insomnia and restless legs syndrome. Sleep 41, pii: 5095658 (2018). 10.1093/sleep/zsy164
54. Cross-Disorder Group of the Psychiatric Genomics, C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).
55. Tranah, G. J. et al. APOEepsilon4 and slow wave sleep in older adults. PLoS ONE 13, e0191281 (2018).
56. Klimentidis, Y. C. et al. Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE. Int. J. Obes. (Lond). 42, 1161–1176 (2018).
57. Fry, A. et al. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026–1034 (2017).
58. Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
59. Leary, E. B. et al. Periodic limb movements in sleep: Prevalence and associated sleepiness in the Wisconsin Sleep Cohort. Clin. Neurophysiol. 129, 2306–2314 (2018).
60. Senaratna, C. V. et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep. Med. Rev. 34, 70–81 (2017).
61. Lichstein, K. L. et al. Actigraphy validation with insomnia. Sleep 29, 232–239 (2006).
62. Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
63. Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
64. Doherty, A. et al. Large scale population assessment of physical activity using wrist worn accelerometers: The UK Biobank Study. PLoS ONE 12, e0169649 (2017).
65. van Hees, V. T. et al. Autocalibration of accelerometer data for free-living physical activity assessment using local gravity and temperature: an evaluation on four continents. J. Appl. Physiol. (1985) 117, 738–744 (2014).
66. van Hees, V. T. et al. Separating movement and gravity components in an acceleration signal and implications for the assessment of human daily physical activity. PLoS ONE 8, e61691 (2013).
67. Loh, P. R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).
68. Price, A. L. et al. Long-range LD can confound genome scans in admixed populations. Am. J. Hum. Genet. 83, 132–135 (2008).
69. Antypa, N., Vogelzangs, N., Meesters, Y., Schoevers, R. & Penninx, B. W. Chronotype associations with depression and anxiety disorders in a large cohort study. Depress. Anxiety 33, 75–83 (2016).
70. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
71. Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
72. Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
73. Consortium, G. T. Human genomics. The Genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
74. MacArthur, J. et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucl. Acids Res. 45, D896–D901 (2017).
75. Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int. J. Epidemiol. 45, 1961–1974 (2016).
76. Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304–314 (2016).
77. Bowden, J. et al. Improving the accuracy of two-sample summary data Mendelian randomization: moving beyond the NOME assumption. bioRxiv, 159442 (2018).